What is Ibere Pharmaceuticals (IBER) stock price today?

Ibere Pharmaceuticals (IBER) is currently trading at $10.18, down 0.29% today.

What is IBER P/E ratio?

Ibere Pharmaceuticals's P/E ratio is 29.94. This is near the market average.

What is IBER return on equity (ROE)?

Ibere Pharmaceuticals's return on equity (ROE) is 2.46%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Ibere Pharmaceuticals's market cap?

Ibere Pharmaceuticals has a market capitalization of $175.60M.

NYSE · Shell Companies

Ibere Pharmaceuticals (IBER) Stock

$10.18 -0.29% NYSE: IBER Financial Services

Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities.

Valuation

Metric	Value
Price	$10.18
Market Cap	$175.60M
P/E Ratio	29.94
P/B Ratio	0.92
P/S Ratio	0.00
EPS (TTM)	$0.34
52-Week High	$10.75
52-Week Low	$9.75
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.46%
ROA	1.13%
ROCE	-0.73%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	1.86

Annual Financials (USD)

Metric	2020	2021
Revenue	—	$0
Operating Profit	—	$-1.0M
Net Profit	—	$2.0M
EPS	—	$0.34
Op Margin	—	—

Balance Sheet (USD)

Metric	2020	2021
Total Assets	$1.0M	$139.0M
Total Liabilities	$1.0M	$12.0M
Cash	$0	$0
Borrowings	$0	$0

Latest News

AMD Stock Soars 12.7% as AI Rally Revives Data-Center Bets GuruFocus.com · Jul 30, 2026 UEFA says will boycott World Cup if FIFA pushes private investor proposal AFP · Jul 30, 2026 Tesla Rival BYD Just Entered Musk's Next Big Market GuruFocus.com · Jul 30, 2026 Fendi’s New Denim Collection Elevates Banana Fiber to Luxury Fashion Sourcing Journal · Jul 30, 2026 SlimTide Official Website 2026: Launch Effective Weight Loss Formula for Healthy Digestion and Metabolism. Slim Tide capsules Highlights Ingredients, Supplement Facts. GlobeNewswire · Jul 30, 2026

Cash Flow (USD)

Metric	2020	2021
Operating Cash Flow	—	$-1.0M
Investing Cash Flow	—	$-138.0M
Financing Cash Flow	—	$139.0M
Net Cash Flow	—	$0
Free Cash Flow	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.02
EV / EBITDA	-174.45
FCF Yield	-0.49%
Quick Ratio	1.86
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APCAAP Acquisition Corp.	$11.45	-0.04%	67.35	$178.79M	0.00%
BTWNBridgetown Holdings Limited	$6.15	-4.06%	—	$184.30M	0.00%
FSNBFusion Acquisition Corp. II	$10.49	-0.19%	38.85	$178.07M	0.00%
LCWLearn CW Investment Corporation	$10.87	-7.09%	77.64	$164.01M	0.00%
NFYSEnphys Acquisition Corp.	$11.00	+0.09%	28.95	$163.71M	0.00%

About Ibere Pharmaceuticals

Ibere Pharmaceuticals is headquartered in US.

Ibere Pharmaceuticals (IBER) stock trades at $10.18 with a market capitalization of $175.60M. The stock is valued at a price-to-earnings (P/E) ratio of 29.94, price-to-book of 0.92, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.75 and $10.75, and currently trades 5.3% below its 52-week high.

On profitability, Ibere Pharmaceuticals generates a return on equity (ROE) of 2.46%, return on capital employed of -0.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.iberepharma.com